Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CVS Health Corp (CVS): A High Dividend Growth Machine To Consider

CVS Health Corp (NYSE:CVS), together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

The company announced that it is raising its quarterly dividend by 17.60% to 50 cents/share. This is the fourteenth consecutive annual dividend increase for this dividend achiever. In addition, with a new $15 billion share repurchase authorization, the company now has more than $18 billion authorized to be used for share repurchases over the next few years.

mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

Wichy/Shutterstock.com

Over the past decade, the company has managed to boost dividends at a rate of 25.40%/year. This is some impressive dividend growth out there for CVS Health Corp (NYSE:CVS) shareholders. However, I would expect that this rate of annual dividend growth to slow down a little over the next decade. If CVS Health managed to grow dividends at a rate of 10%/year, supported by strong earnings growth from here, I would be a happy camper.

This was supported by a solid 12.30% average increase in annual EPS over the past decade, and a low payout ratio. I analyzed the company in November, and initiated a position around that time. Please check my analysis of CVS Health Corp (NYSE:CVS) for more information about the company.

Currently, CVS is attractively valued at 16.40 times forward earnings and a yield of 2.50%. I took advantage of the huge sell-off last month and initiated a small new position in the stock. Given the rapid increase in dividends, I think that the stock is a good value today.

Follow Cvs Health Corp (NYSE:CVS)
Trade (NYSE:CVS) Now!

Full Disclosure: Long CVS and WBA

Loading...